Investigation launched into securities fraud at Novo Nordisk A/S

Glancy Prongay & Murray LLP, a respected national law firm focusing on protecting shareholder rights, has initiated an investigation concerning potential violations of federal securities laws by Novo Nordisk A/S (referred to as “Novo Nordisk” or the “Company”) (NYSE: NVO) that may have impacted investors.

The catalyst for this inquiry occurred on June 23, 2025, when Novo Nordisk decided to terminate its collaboration with Hims & Hers Health, Inc. (“Hims”) and discontinue the availability of its weight loss medication, Wegovy, through Hims. This decision was made due to allegations that Hims had violated regulations prohibiting large-scale sales of compounded drugs under the pretense of personalization and engaging in deceptive marketing practices that endangered patient safety.

Following this announcement, Novo Nordisk’s stock price experienced a significant decline of $4.05, representing a 5.5% drop, with shares closing at $69.72 on June 23, 2025. This decrease had adverse consequences for investors who held positions in the Company.

Investors who have suffered financial losses as a result of these events are encouraged to reach out to Glancy Prongay & Murray LLP to explore their potential legal options and to obtain more information about participating in the investigation. Concerned individuals can contact Charles Linehan, Esq., at Glancy Prongay & Murray LLP by visiting their office at 1925 Century Park East, Suite 2100, Los Angeles, California 90067, or by getting in touch via email or phone.

Furthermore, individuals who possess confidential information related to Novo Nordisk are urged to consider assisting in the investigation or taking advantage of the SEC Whistleblower Program. Whistleblowers who provide original information to the SEC may be eligible to receive rewards amounting to up to 30% of any successful recovery made by the SEC. For more details about this program, individuals can contact Charles H. Linehan at the provided email address or phone number.

Glancy Prongay & Murray LLP, recognized as a premier law firm representing investors and consumers in securities litigation and other complex class action cases, has a track record of securing substantial settlements and delivering results for their clients. With nearly 40 attorneys located in four offices nationwide, GPM has achieved significant milestones in various legal actions, recovering billions of dollars for investors and consumers in areas such as securities, antitrust, consumer, and employment class actions.

It is essential to note that this press release may be categorized as Attorney Advertising in specific jurisdictions based on applicable laws and ethical standards. Interested parties can find additional information and contact details by visiting the source version of this release on the Business Wire website.